SCHEMBL9724694

SCHEMBL9724694

CCCCCc1noc(C2CN3CCC2C3)n1

nearest known ligand 0.81

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 3/20 0.59
CHRM1 P11229 2/20 0.56
CHRM4 P08173 1/20 0.39
CHRM5 P08912 1/20 0.39
CHRM3 P20309 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10521548 0.96 CHRM2 (0.60) CHRM2CHRM1
SCHEMBL24434414 0.94 CHRM2 (0.50) CHRM2CHRM1
SCHEMBL9528809 0.90 CHRM2 (0.51) CHRM2CHRM1
Hydrochloric Acid SCHEMBL10519400 0.90 CHRM2 (0.62) CHRM2CHRM1
SCHEMBL9724677 0.83 CHRM2 (0.64) CHRM2CHRM1
Oxalic Acid SCHEMBL9404508 0.83 CHRM2 (0.46) CHRM2CHRM1CHRM4CHRM5CHRM3
Oxalic Acid SCHEMBL9213578 0.79 CHRM2 (0.58) CHRM2CHRM1
SCHEMBL9724682 0.78 CHRM2 (0.56) CHRM2CHRM1
SCHEMBL9446638 0.76 CHRM2 (0.51) CHRM2CHRM1
Oxadiazole SCHEMBL9369455 0.72 CHRM2 (1.00) CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0459568-A2 Substituted oxadiazoles and thiadiazoles for use in the treatment of glaucoma and novel compounds having such use MERCK SHARP & DOHME LTD. (GB) 1991-12-04 EP claimed
US-5134146-A SUBSTITUTED OXADIAZOLES AND THIADIAZOLES FOR USE IN THE TREATMENT OF GLAUCOMA MERCK SHARP AND DOHME LTD. (GB) 1992-07-28 US disclosed
EP-0459568-A2 Substituted oxadiazoles and thiadiazoles for use in the treatment of glaucoma and novel compounds having such use MERCK SHARP & DOHME LTD. (GB) 1991-12-04 EP disclosed